Zobrazeno 1 - 10
of 30
pro vyhledávání: '"I.M. Visman"'
Autor:
M. T. Nurmohamed, Maria A. C. van der Weijden, Tamara Rusman, Willem F. Lems, Johannes Christiaan van Denderen, Kimberley Johanna Beek, Maria Konsta, I.M. Visman, Irene E. van der Horst-Bruinsma
Publikováno v:
Beek, K J, Rusman, T, van der Weijden, M A C, Lems, W F, van Denderen, J C, Konsta, M, Visman, I, Nurmohamed, M T & van der Horst-Bruinsma, I E 2019, ' Long-Term Treatment With TNF-Alpha Inhibitors Improves Bone Mineral Density But Not Vertebral Fracture Progression in Ankylosing Spondylitis ', Journal of Bone and Mineral Research, vol. 34, no. 6, pp. 1041-1048 . https://doi.org/10.1002/jbmr.3684
Journal of Bone and Mineral Research, 34(6), 1041-1048. Wiley-Blackwell
Journal of Bone and Mineral Research, 34(6), 1041-1048. Wiley-Blackwell
The aim of this cohort study was to evaluate the long-term effects of TNF inhibitors (TNFis) on BMD and the incidence of vertebral fractures (VFxs) in patients with ankylosing spondylitis (AS). Consecutive patients with active AS with TNFi treatment
Favorable effects on the hemostatic system in ankylosing spondylitis patients treated with golimumab
Autor:
M. T. Nurmohamed, Maaike Heslinga, I.M. Visman, Joost C. M. Meijers, Christiaan J. van Denderen, Irene E. van der Horst-Bruinsma, Andreas Miltenburg
Publikováno v:
Joint, bone, spine, 88(2):105102. Elsevier Masson
Joint Bone Spine, 88
Visman, I, Heslinga, M, van Denderen, C, van der Horst-Bruinsma, I, Miltenburg, A, Meijers, J & Nurmohamed, M 2021, ' Favorable effects on the hemostatic system in ankylosing spondylitis patients treated with golimumab ', Joint Bone Spine, vol. 88, no. 2, 105102 . https://doi.org/10.1016/j.jbspin.2020.105102
Joint Bone Spine, 88(2):105102. Elsevier Masson
Joint Bone Spine, 88, 2
Joint Bone Spine, 88
Visman, I, Heslinga, M, van Denderen, C, van der Horst-Bruinsma, I, Miltenburg, A, Meijers, J & Nurmohamed, M 2021, ' Favorable effects on the hemostatic system in ankylosing spondylitis patients treated with golimumab ', Joint Bone Spine, vol. 88, no. 2, 105102 . https://doi.org/10.1016/j.jbspin.2020.105102
Joint Bone Spine, 88(2):105102. Elsevier Masson
Joint Bone Spine, 88, 2
Item does not contain fulltext
Autor:
I.M. Visman, Willem F. Lems, Sebastian Ibanez Vodnizza, Michael T. Nurmohamed, Francisca Jaime, Christiaan J. van Denderen, Irene E. van der Horst-Bruinsma
Publikováno v:
Rheumatology (Oxford, England), 56(9), 1566-1572. Oxford University Press
Ibáñez Vodnizza, S, Visman, I M, van Denderen, C, Lems, W F, Jaime, F, Nurmohamed, M T & van der Horst-Bruinsma, I E 2017, ' Muscle wasting in male TNF-α blocker naïve ankylosing spondylitis patients : a comparison of gender differences in body composition ', Rheumatology (Oxford, England), vol. 56, no. 9, pp. 1566-1572 . https://doi.org/10.1093/rheumatology/kex187
Ibáñez Vodnizza, S, Visman, I M, van Denderen, C, Lems, W F, Jaime, F, Nurmohamed, M T & van der Horst-Bruinsma, I E 2017, ' Muscle wasting in male TNF-α blocker naïve ankylosing spondylitis patients : a comparison of gender differences in body composition ', Rheumatology (Oxford, England), vol. 56, no. 9, pp. 1566-1572 . https://doi.org/10.1093/rheumatology/kex187
Objective: To assess gender differences in body composition (BC) in a cohort of AS patients naïve to TNF-α blockers.Methods: Patients included fulfilled the Modified New York criteria for AS. Demographic information and disease activity measures (A
Autor:
I.M. Visman, C. van Denderen, Michael T. Nurmohamed, I.A. Swart, Maaike Heslinga, I E van der Horst-Bruinsma
Publikováno v:
Spondyloarthritis – treatment.
Background Impaired renal function is common in patients with ankylosing spondylitis (AS) and patients also have an increased risk of cardiovascular disease (CVD). Previous studies showed that biologicals, such as anti-Tumour Necrosis Factor (anti-TN
Autor:
Sebastián E Ibáñez Vodnizza, J Christiaan van Denderen, Irene E van der Horst-Bruinsma, Michael T Nurmohamed, I.M. Visman, Willem F Lems, Francisca Jaime
Publikováno v:
Vodnizza, S E I, Nurmohamed, M T, Visman, I M, Christiaan Van Denderen, J, Lems, W F, Jaime, F & Van Der Horst-Bruinsma, I E 2017, ' Fat mass lowers the response to tumor necrosis factor-a blockers in patients with ankylosing spondylitis ', Journal of Rheumatology, vol. 44, no. 9, pp. 1355-1361 . https://doi.org/10.3899/jrheum.170094
Journal of Rheumatology, 44(9), 1355-1361. Journal of Rheumatology
Journal of Rheumatology, 44(9), 1355-1361. Journal of Rheumatology
Objective.Our main objective was to assess the relationship between body composition (BC) and response to tumor necrosis factor-α (TNF-α) blocker treatment in patients with ankylosing spondylitis (AS). Our secondary objective was to evaluate the ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fc0c8ad7de292b87796a4d0c39d82d5
https://research.vumc.nl/en/publications/b48cd4a8-2e95-454c-8d52-566b7552deb6
https://research.vumc.nl/en/publications/b48cd4a8-2e95-454c-8d52-566b7552deb6
Autor:
I E van der Horst-Bruinsma, Michael T. Nurmohamed, Tamara Rusman, J. C. van Denderen, I.M. Visman
Publikováno v:
Poster Presentations.
Background Limited data are available on the influence of gender and lifestyle factors, such as smoking, alcohol consumption and Body Mass Index (BMI) on disease activity and response to TNF inhibitors (TNFi) in ankylosing spondylitis (AS). Objective
Autor:
Ie der horst-Bruinsma van, Michael T. Nurmohamed, JC Denderen van, W.F. Lems, I.M. Visman, SE Vodnizza Ibáñez
Publikováno v:
Poster Presentations.
Background Female Ankylosing Spondylitis (AS) patients have different disease characteristics compared to males. This might be explained by differences in body composition (BC), as women have higher total body fat mass, and adipose tissue can produce
Autor:
Maria Konsta, Michael T. Nurmohamed, J.C. van Denderen, I E van der Horst-Bruinsma, Alexios Iliopoulos, P.P. Sfikakis, I.M. Visman
Publikováno v:
Poster Presentations.
Background Although there is debate whether treatment with TNF inhibitors (TNFi) in AS may not inhibit spinal radiographic progression, the effect on hip involvement may be different (1,2). Objectives To estimate the impact of long-term TNFi treatmen
Autor:
Ie der horst-Bruinsma van, SE Ibáñez Vodnizza, Michael T. Nurmohamed, J.C. van Denderen, W.F. Lems, I.M. Visman
Publikováno v:
Poster Presentations.
Background Women with Ankylosing Spondylitis (AS) seem to be less responsive to TNF-α blockers and have a shorter drug survival. This might be explained by differences in body composition (BC), as women have higher total body fat (BF). Objectives As
Autor:
Michael T. Nurmohamed, J.C. van Denderen, Alexios Iliopoulos, P.P. Sfikakis, I.M. Visman, Maria Konsta, I E van der Horst-Bruinsma
Publikováno v:
Poster Presentations.
Background Hip involvement is the most frequent extraspinal arthritic manifestation of Ankylosing Spondylitis (AS) and a common cause of disability. It is present in 24% to 36% of AS patients, leading to total hip replacement (THR) in 5%. Objectives